Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

NCT05976763 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

421

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: Zanubrutinib
BIOLOGICAL: Rituximab
OTHER: Patient Observation
PROCEDURE: Bone Marrow Biopsy
OTHER: Fludeoxyglucose F-18
PROCEDURE: Positron Emission Tomography
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Esophagogastroduodenoscopy
PROCEDURE: Colonoscopy
PROCEDURE: Biospecimen Collection
OTHER: Questionnaire Administration

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]